{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,18]],"date-time":"2026-01-18T11:30:49Z","timestamp":1768735849090,"version":"3.49.0"},"reference-count":17,"publisher":"Springer Science and Business Media LLC","issue":"6","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Eur J Nucl Med Mol Imaging"],"published-print":{"date-parts":[[2011,6]]},"DOI":"10.1007\/s00259-011-1783-3","type":"journal-article","created":{"date-parts":[[2011,4,1]],"date-time":"2011-04-01T19:44:24Z","timestamp":1301687064000},"page":"1132-1138","source":"Crossref","is-referenced-by-count":15,"title":["Vascular time-activity variation in patients undergoing 123I-MIBG myocardial scintigraphy: implications for quantification of cardiac and mediastinal uptake"],"prefix":"10.1007","volume":"38","author":[{"given":"Hein J.","family":"Verberne","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Derk O.","family":"Verschure","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"G. Aernout","family":"Somsen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Berthe L. F.","family":"van Eck-Smit","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Arnold F.","family":"Jacobson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2011,4,2]]},"reference":[{"key":"1783_CR1","doi-asserted-by":"crossref","first-page":"819","DOI":"10.1056\/NEJM198409273111303","volume":"311","author":"JN Cohn","year":"1984","unstructured":"Cohn JN, Levine TB, Olivari MT, Garberg V, Lura D, Francis GS, et al. Plasma norepinephrine as a guide to prognosis in patients with chronic congestive heart failure. N Engl J Med 1984;311:819\u201323.","journal-title":"N Engl J Med"},{"key":"1783_CR2","doi-asserted-by":"crossref","first-page":"1147","DOI":"10.1093\/eurheartj\/ehn113","volume":"29","author":"HJ Verberne","year":"2008","unstructured":"Verberne HJ, Brewster LM, Somsen GA, van Eck-Smit BL. Prognostic value of myocardial 123I-metaiodobenzylguanidine (MIBG) parameters in patients with heart failure: a systematic review. Eur Heart J 2008;29:1147\u201359.","journal-title":"Eur Heart J"},{"key":"1783_CR3","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1007\/s00259-007-0639-3","volume":"35","author":"D Agostini","year":"2008","unstructured":"Agostini D, Verberne HJ, Burchert W, Knuuti J, Povinec P, Sambuceti G, et al. I-123-mIBG myocardial imaging for assessment of risk for a major cardiac event in heart failure patients: insights from a retrospective European multicenter study. Eur J Nucl Med Mol Imaging 2008;35:535\u201346.","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"1783_CR4","doi-asserted-by":"crossref","first-page":"2212","DOI":"10.1016\/j.jacc.2010.01.014","volume":"55","author":"AF Jacobson","year":"2010","unstructured":"Jacobson AF, Senior R, Cerqueira MD, Wong ND, Thomas GS, Lopez VA, et al. Myocardial iodine-123 meta-iodobenzylguanidine imaging and cardiac events in heart failure. Results of the prospective ADMIRE-HF (AdreView Myocardial Imaging for Risk Evaluation in Heart Failure) study. J Am Coll Cardiol 2010;55:2212\u201321.","journal-title":"J Am Coll Cardiol"},{"key":"1783_CR5","first-page":"129","volume":"22","author":"RC Kline","year":"1981","unstructured":"Kline RC, Swanson DP, Wieland DM, Thrall JH, Gross MD, Pitt B, et al. Myocardial imaging in man with I-123 meta-iodobenzylguanidine. J Nucl Med 1981;22:129\u201332.","journal-title":"J Nucl Med"},{"key":"1783_CR6","doi-asserted-by":"crossref","first-page":"798","DOI":"10.1007\/s00259-007-0668-y","volume":"35","author":"HJ Verberne","year":"2008","unstructured":"Verberne HJ, Busemann Sokole E, van Moerkerken A, Deeterink J, Ensing G, Stabin M, et al. Clinical performance and radiation dosimetry of no-carrier-added vs carrier-added 123I-metaiodobenzylguanidine (MIBG) for the assessment of cardiac sympathetic nerve activity. Eur J Nucl Med Mol Imaging 2008;35:798\u2013807.","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"1783_CR7","doi-asserted-by":"crossref","first-page":"2660","DOI":"10.1161\/01.CIR.95.12.2660","volume":"95","author":"KD Aaronson","year":"1997","unstructured":"Aaronson KD, Schwartz JS, Chen TM, Wong KL, Goin JE, Mancini DM. Development and prospective validation of a clinical index to predict survival in ambulatory patients referred for cardiac transplant evaluation. Circulation 1997;95:2660\u20137.","journal-title":"Circulation"},{"key":"1783_CR8","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/S0272-6386(12)80859-6","volume":"21","author":"JM Flack","year":"1993","unstructured":"Flack JM, Neaton JD, Daniels B, Esunge P. Ethnicity and renal disease: lessons from the Multiple Risk Factor Intervention Trial and the Treatment of Mild Hypertension Study. Am J Kidney Dis 1993;21:31\u201340.","journal-title":"Am J Kidney Dis"},{"key":"1783_CR9","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1161\/CIRCIMAGING.108.782433","volume":"1","author":"JJ Bax","year":"2008","unstructured":"Bax JJ, Kraft O, Buxton AE, Fjeld JG, Par\u00edzek P, Agostini D, et al. 123I-mIBG scintigraphy to predict inducibility of ventricular arrhythmias on cardiac electrophysiology testing: a prospective multicenter pilot study. Circ Cardiovasc Imaging 2008;1:131\u201340.","journal-title":"Circ Cardiovasc Imaging"},{"key":"1783_CR10","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1159\/000180580","volume":"16","author":"DW Cockcroft","year":"1976","unstructured":"Cockcroft DW, Gault MH. Prediction of creatinine clearance from serum creatinine. Nephron 1976;16:31\u201341.","journal-title":"Nephron"},{"key":"1783_CR11","doi-asserted-by":"crossref","first-page":"461","DOI":"10.7326\/0003-4819-130-6-199903160-00002","volume":"130","author":"AS Levey","year":"1999","unstructured":"Levey AS, Bosch JP, Lewis JB, Greene T, Rogers N, Roth D. A more accurate method to estimate glomerular filtration rate from serum creatinine: a new prediction equation. Modification of Diet in Renal Disease Study Group. Ann Intern Med 1999;130:461\u201370.","journal-title":"Ann Intern Med"},{"key":"1783_CR12","unstructured":"Tomson C, Blades S, Burden R, Cunningham J, Dennis J, Gilbert D, et al. Chronic kidney disease in adults. In: UK guidelines for identification, management and referral. 2009. Available at: http:\/\/www.renal.org\/CKDguide\/full\/CKDprintedfullguide.pdf . Accessed 26 Jan 2011."},{"key":"1783_CR13","doi-asserted-by":"crossref","first-page":"1322","DOI":"10.1007\/s00259-009-1093-1","volume":"36","author":"HJ Verberne","year":"2009","unstructured":"Verberne HJ, Somsen GA, Povinec P, van Eck-Smit BL, Jacobson AF. Impact of mediastinal, liver and lung (123)I-metaiodobenzylguanidine ((123)I-MIBG) washout on calculated (123)I-MIBG myocardial washout. Eur J Nucl Med Mol Imaging 2009;36:1322\u20138.","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"1783_CR14","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1152\/physrev.1997.77.1.75","volume":"77","author":"GF DiBona","year":"1997","unstructured":"DiBona GF, Kopp UC. Neural control of renal function. Physiol Rev 1997;77:75\u2013197.","journal-title":"Physiol Rev"},{"key":"1783_CR15","doi-asserted-by":"crossref","first-page":"1913","DOI":"10.1172\/JCI112187","volume":"76","author":"V Kon","year":"1985","unstructured":"Kon V, Yared A, Ichikawa I. Role of renal sympathetic nerves in mediating hypoperfusion of renal cortical microcirculation in experimental congestive heart failure and acute extracellular fluid volume depletion. J Clin Invest 1985;76:1913\u201320.","journal-title":"J Clin Invest"},{"key":"1783_CR16","first-page":"618","volume":"15","author":"GM Blake","year":"1989","unstructured":"Blake GM, Lewington VJ, Zivanovic MA, Ackery DM. Glomerular filtration rate and the kinetics of 123I-metaiodobenzylguanidine. Eur J Nucl Med 1989;15:618\u201323.","journal-title":"Eur J Nucl Med"},{"key":"1783_CR17","first-page":"544","volume":"24","author":"AR Wafelman","year":"1997","unstructured":"Wafelman AR, Hoefnagel CA, Maessen HJ, Maes RA, Beijnen JH. Renal excretion of iodine-131 labelled meta-iodobenzylguanidine and metabolites after therapeutic doses in patients suffering from different neural crest-derived tumours. Eur J Nucl Med 1997;24:544\u201352.","journal-title":"Eur J Nucl Med"}],"container-title":["European Journal of Nuclear Medicine and Molecular Imaging"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00259-011-1783-3","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,6,9]],"date-time":"2019-06-09T16:15:08Z","timestamp":1560096908000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00259-011-1783-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,4,2]]},"references-count":17,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2011,6]]}},"alternative-id":["1783"],"URL":"https:\/\/doi.org\/10.1007\/s00259-011-1783-3","relation":{},"ISSN":["1619-7070","1619-7089"],"issn-type":[{"value":"1619-7070","type":"print"},{"value":"1619-7089","type":"electronic"}],"subject":[],"published":{"date-parts":[[2011,4,2]]}}}